Loading clinical trials...

Digital Therapeutic Workplace Technology as a Employee Management Tool and Employee's Mental Health Care | Clinical Trials | Clareo Health

COMPLETEDNA

Digital Therapeutic Workplace Technology as a Employee Management Tool and Employee's Mental Health Care

How Social Ventures Boost Performance and Sustain Businesses With Digital Therapeutic Workplace Technology (Smartphone App 'Maro') Designed to Support Individual Employee's Mental Health

NCT06295185•Ajou University School of Medicine

View on ClinicalTrials.gov

Summary

The purpose of the study is to determine whether a digital healthcare app for employee's mental health can effectively improve the mental health of Hisbeans's employees and the managerial performance of Hisbeans, which is represented as a 'social enterprise'.

Detailed Description

Hisbeans is a social enterprise where employees are consist of individual with mental disabilities. 'Hisbeans' employees(N = 150 subjects) will be randomly assigned to Group 1 (maro intervention), or Group 2 (control app intervention) by cluster randomization depending on the branch of the company. * MARO intervention group: MARO (mental health digital application) use * Control group: sham app use The intervention period will be 8weeks.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. HISBEANS store employees
•2. Age: 18 years old or older
•3. possessing a smartphone with internet connection
•4. subjects agree to participate in the study

Exclusion Criteria

•1. Those who have symptoms of psychotic disorder are acutely active or advanced, making clinical intervention difficult
•2. Those who has been started or changed their antidepressant medication within the last 1 month or cannot be maintained stably during the intervention period
•3. Those who are non-literate
•4. Those who have used the Maro app previously
•5. Those who couldn't use Maro app in their own smartphone
•6. Those who participate in another intervention study
•7. Those who have a serious medical condition that prevents them from participating in the intervention and efficacy evaluation
•8. Those who is unable to participate fully and cooperatively by the judgment of the researcher

Locations (1)

Ajou Medical University

Suwon, South Korea

Key Dates

Start Date

May 20, 2024

Primary Completion Date

July 31, 2024

Completion Date

July 31, 2024

Last Updated

September 19, 2024

Enrollment

165

ACTUAL participants

Conditions

DepressionMental Health Issue

Interventions

application MARO

OTHER

Sham application

OTHER

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITING

GENESIS Project: Generating Evidence on the Needs of Ecuadorian Adolescents

NCT07485673

Adolescent DevelopmentMental Health Issue+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Digital Therapeutic Workplace Technology as a Employee Management Tool and Employee's Mental Health Care

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

GENESIS Project: Generating Evidence on the Needs of Ecuadorian Adolescents

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Gii'Igoshimong: Sitting With Your First Family